Genome-wide CRISPR-Cas9 screening identifies genetic vulnerabilities and potential therapeutic targets in castration resistant prostate cancer

被引：0
|
作者：
Haldrup, Jakob [1 ]
Schmidt, Linnea [1 ]
Pedersen, Jakob S. [1 ]
Sorensen, Karina D. [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Mol Med MOMA, Aarhus N, Denmark
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-5899
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5899
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Large-scale genome-wide CHANGE-seq profiling of CRISPR-Cas9 therapeutic targets reveals genetic and epigenetic determinants of activity
    Lazzarotto, Cicera R.
    Malinin, Nikolay
    Katta, Varun
    Li, Yichao
    Cheng, Yong
    Tsai, Shengdar Q.
    TRANSGENIC RESEARCH, 2020, 29 (04) : 473 - 473
  • [32] CRISPR-Cas9 genome editing in iPSCs for functional genetic screening
    Isachenko, Nadja
    Hu, Dongfang
    Chenchik, Alex
    Diehl, Paul
    Tedesco, Donato
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [33] CRISPR-Cas9 genome editing in iPSCs for functional genetic screening
    Isachenko, N.
    Hu, D.
    Chenchik, A.
    Diehl, P.
    Tedesco, D.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 859 - 859
  • [34] Whole exome sequencing identifies potential therapeutic targets for castration resistant prostate cancer
    Menon, R.
    Deng, M.
    Boehm, D.
    Fend, F.
    Biskup, S.
    Perner, S.
    VIRCHOWS ARCHIV, 2012, 461 : S42 - S43
  • [35] Whole Exome Sequencing Identifies Potential Therapeutic Targets for Castration Resistant Prostate Cancer
    Menon, R.
    Deng, M.
    Boehm, D.
    Fend, F.
    Boehm, D.
    Biskup, S.
    Perner, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S195 - S195
  • [36] Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer
    Chune Yu
    Dan Luo
    Jing Yu
    Min Zhang
    Xiaobo Zheng
    Guangchao Xu
    Jiaxin Wang
    Huiling Wang
    Yufei Xu
    Ke Jiang
    Jie Xu
    Xuelei Ma
    Jing Jing
    Hubing Shi
    Oncogene, 2022, 41 : 191 - 203
  • [37] Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer
    Yu, Chune
    Luo, Dan
    Yu, Jing
    Zhang, Min
    Zheng, Xiaobo
    Xu, Guangchao
    Wang, Jiaxin
    Wang, Huiling
    Xu, Yufei
    Jiang, Ke
    Xu, Jie
    Ma, Xuelei
    Jing, Jing
    Shi, Hubing
    ONCOGENE, 2022, 41 (02) : 191 - 203
  • [38] Genome-wide CRISPR-cas9 screening identifies KDM6A as a modulator of CD38 expression in multiple myeloma: Therapeutic implications.
    Liu, Jiye
    Xing, Lijie
    Hideshima, Teru
    Anderson, Kenneth Carl
    CANCER RESEARCH, 2022, 82 (12)
  • [39] A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase
    Jin, Da-Yun
    Chen, Xuejie
    Liu, Yizhou
    Williams, Craig M.
    Pedersen, Lars C.
    Stafford, Darrel W.
    Tie, Jian-Ke
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [40] Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
    Behan, Fiona M.
    Iorio, Francesco
    Picco, Gabriele
    Goncalves, Emanuel
    Beaver, Charlotte M.
    Migliardi, Giorgia
    Santos, Rita
    Rao, Yanhua
    Sassi, Francesco
    Pinnelli, Marika
    Ansari, Rizwan
    Harper, Sarah
    Jackson, David Adam
    Mcrae, Rebecca
    Pooley, Rachel
    Wilkinson, Piers
    van der Meer, Dieudonne
    Dow, David
    Buser-Doepner, Carolyn
    Bertotti, Andrea
    Trusolino, Livio
    Stronach, Euan A.
    Saez-Rodriguez, Julio
    Yusa, Kosuke
    Garnett, Mathew J.
    NATURE, 2019, 568 (7753) : 511 - +
12345